IARS1 and cancer: The inhibitory effects of mTORC1 and/or S6K towards IRS constitutes a prominent negative feedback loop in the PI3K/Akt/mTORC1 signalling axis, and has been implicated in insulin resistance56 as well as resistance to anti-cancer drugs57.